| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b0c620148d1cc4728c58045bbf0749c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d002df3577e0f42ac4db95d943c56da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6dfffb748bb9a9496143919abc661d52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_996f034786c8efdbc6eb3feb240228cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_291791fe9ad3c647fe944161326458c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26732f2a4ad9b05497c5afaa1169141c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5778acfaf26662d9be54245e6e02a56 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6827 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2012-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca7cc570ef57458740539bc83b6495a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_261dd4be97b27521b73fd7d91fc3db53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8b4cd912f31377ca8d304200df782f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ee8f595df76a94287a9299166d7851c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cee85f47d53ac638367f7fdbbab1029d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c259ae2b19a225a07f75da6ef05695b9 |
| publicationDate |
2014-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014221230-A1 |
| titleOfInvention |
Thromboembolic disease markers |
| abstract |
The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114410766-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10023914-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10557170-B2 |
| priorityDate |
2011-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |